QPPV.COM KNOWLEDGE ASSESSMENT

SSRIs and Postpartum Haemorrhage: Signal Evaluation Knowledge Assessment

Test your understanding of the concepts covered by SSRIs and Postpartum Haemorrhage: A Signal Evaluation.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Why should the large apparent effect in a hospital-based cohort not be interpreted as an unadjusted SSRI effect?

The study included only women with mood disorders, so no comparison was possible Exposed and unexposed women differed in factors such as BMI, smoking and epidural analgesia Odds ratios cannot be used for bleeding outcomes Hospital-based studies cannot measure absolute risks

Question 2 of 10 Why is benefit-risk assessment particularly important when considering a possible SSRI-related PPH risk?

Because untreated or inadequately treated maternal depression and anxiety may also cause clinically important harm Because any possible risk automatically outweighs the benefits of treatment Because antidepressant exposure has no therapeutic benefit during pregnancy Because benefit-risk assessment can establish whether the association is causal

Question 3 of 10 What inference is most justified by the finding that current and recent exposure were associated with PPH, whereas past exposure was not clearly associated?

The finding provides temporal coherence with a mechanism operating near delivery The finding proves that all late-pregnancy associations are causal The finding shows that remote exposure protects against PPH The finding demonstrates that confounding is absent

Question 4 of 10 Which conclusion would be overreaching based on the evidence described in the article?

Late-pregnancy antidepressant exposure is associated with a small increase in PPH risk in observational studies The association warrants continued pharmacovigilance attention Residual confounding related to maternal psychiatric illness remains important The observed association is entirely explained by platelet serotonin effects

Question 5 of 10 If the baseline PPH risk is approximately 5%, what approximate risk would correspond to a relative risk of 1.4?

Approximately 5.4% Approximately 6.0% Approximately 7.0% Approximately 9.0%

Question 6 of 10 A study reports an adjusted relative risk of 1.47 and an adjusted excess risk of 1.26 percentage points for current serotonin reuptake inhibitor exposure. How should these results be communicated?

Only the relative risk should be reported because absolute risk is not relevant to pharmacovigilance Only the excess risk should be reported because relative risk is misleading in all circumstances Both should be reported because they describe relative association and clinical magnitude from different perspectives The results are contradictory and cannot be used together

Question 7 of 10 Which biological sequence best represents the proposed mechanism linking SSRIs with bleeding?

SSRI exposure increases uterine contractions, causing placental separation SSRI exposure reduces platelet serotonin availability, potentially altering platelet-mediated haemostasis SSRI exposure increases red-cell destruction, reducing circulating blood volume SSRI exposure directly causes retained placental tissue

Question 8 of 10 Which statement best distinguishes biological plausibility from causal evidence?

A plausible mechanism is sufficient to confirm an adverse drug reaction A plausible mechanism supports investigation but does not establish clinically important PPH causality A plausible mechanism is less informative than an unadjusted crude association A plausible mechanism proves that obstetric factors are not relevant

Question 9 of 10 Why does an association between PPH and pharmacologically unrelated antidepressants complicate interpretation of an SSRI-specific signal?

It proves that serotonin has no role in haemostasis It suggests that confounding or a broader treatment-related factor may contribute to the observed association It proves that the outcome definitions in all studies were invalid It demonstrates that non-serotonergic antidepressants are more potent platelet inhibitors

Question 10 of 10 What is the most appropriate interpretation of a class-level SSRI signal for individual products?

Every SSRI must have exactly the same risk magnitude No individual product can be associated with the outcome The class-level signal may support further product-specific review but does not automatically establish identical risks for all SSRIs The class-level signal proves that non-SSRI antidepressants have the same pharmacological mechanism

QPPV.com

SSRIs and Postpartum Haemorrhage: Signal Evaluation Knowledge Assessment

Cookie Settings